NSE filing, NSE: THYROCARE. Summary written from the filing by ALFA Finder's alert engine.
Thyrocare Technologies Ltd: key numbers
- Share price
- ₹456.30
- Market cap
- ₹7,263 Cr
- Revenue (annual)
- ₹829.0 Cr
- Net profit (annual)
- ₹163.0 Cr
- P/E (TTM)
- 50.4×Sector 52.8×
- Promoter holding
- 51.02%-9.90% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thyrocare Technologies Ltd
All →Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr
Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.
- Value
- ₹141.4 Cr
Thyrocare Technologies Annual General Meeting
Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.
Thyrocare Technologies Earnings Call Transcript: Key Takeaways
Thyrocare reports robust 24% growth, pivoting from volume-led routine testing to specialized diagnostics under new management. High operational leverage is evident as PAT growth significantly outpaced revenue.
- Call
- Guides 20% growth
Thyrocare Technologies Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹270.8 Cr (+25.1%), EBITDA ₹89.3 Cr (33.0% margin), PAT before exceptions ₹60.2 Cr (+25.7%). Debt-free; NHL radiology divestment pending.
Thyrocare Technologies Results Update
Thyrocare Technologies reported Q2FY27 consolidated revenue of Rs 270.8 Cr, up 25.1% YoY, with PAT before exceptions of Rs 60.2 Cr. The press release also notes a Rs 45 Cr non-cash NHL impairment tied to a proposed divestment.
Thyrocare Technologies Q2 FY27 Results: Net Profit ₹15.2 Cr, Down 68.2% YoY
Thyrocare Technologies Ltd reported revenue from operations of ₹270.8 Cr (+25.1% YoY) and net profit of ₹15.2 Cr (-68.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹15.2 Cr · -68.2% YoY
Other results correction announcements
All →Syschem (India) Results Correction
Syschem India re-submitted its unaudited Q2/H1 FY2026-27 standalone results with the limited review report, following a BSE query. Revenue from operations was Rs 12,979.28 lakh for the quarter, with profit of Rs 191.09 lakh.
Amalgamated Electricity Company Results Correction
Amalgamated Electricity revised its board outcome to correct a director's designation in the September 2026 balance sheet. The resubmission re-encloses the unaudited results and limited review report.
Manipal Payment and Identity Solutions Results Correction
Manipal Payment and Identity Solutions clarified two NSE observations on its 01 October 2026 financial results. It stated it has one operating segment and that the results PDF was machine-readable.
Tamilnad Mercantile Bank Results Correction
TMB clarified its ₹304.24 crore ECL provision is proactive, not a regulatory shortfall. The ECL framework applies from April 2027 under RBI rules.
Punjab National Bank Results Correction
Punjab National Bank re-submitted its unchanged September 2026 quarter and half-year results in machine-readable format. No figures, disclosures or other information were modified from the earlier filing.
Gateway Distriparks Results Correction
Gateway Distriparks issued a revised Q2 FY27 results press release to correct a typographical error in the earlier filing. The financial figures remain materially unchanged.